B & T Capital Management DBA Alpha Capital Management Purchases Shares of 21,684 Grail, Inc. (NASDAQ:GRAL)

B & T Capital Management DBA Alpha Capital Management acquired a new position in Grail, Inc. (NASDAQ:GRAL) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 21,684 shares of the company’s stock, valued at approximately $387,000.

A number of other large investors also recently modified their holdings of GRAL. FNY Investment Advisers LLC purchased a new stake in Grail in the 4th quarter valued at $26,000. A. D. Beadell Investment Counsel Inc. bought a new stake in shares of Grail in the 4th quarter worth $430,000. 180 Wealth Advisors LLC purchased a new stake in shares of Grail in the fourth quarter valued at about $1,681,000. Finally, Douglas Lane & Associates LLC purchased a new stake in shares of Grail in the fourth quarter valued at about $3,034,000.

Insiders Place Their Bets

In other Grail news, CFO Aaron Freidin sold 30,452 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $14.02, for a total transaction of $426,937.04. Following the completion of the transaction, the chief financial officer now directly owns 268,277 shares of the company’s stock, valued at approximately $3,761,243.54. This represents a 10.19 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Grail Trading Up 0.1 %

Shares of NASDAQ:GRAL opened at $17.42 on Friday. The business has a 50-day moving average of $18.32. Grail, Inc. has a fifty-two week low of $12.33 and a fifty-two week high of $24.92.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on GRAL shares. Wolfe Research assumed coverage on shares of Grail in a report on Friday, November 15th. They set a “peer perform” rating on the stock. Guggenheim started coverage on Grail in a research note on Thursday, October 17th. They issued a “neutral” rating on the stock. Finally, Morgan Stanley assumed coverage on Grail in a research report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 price target for the company.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.